These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 27497113)
1. Doping control container for urine stabilization: a pilot study. Tsivou M; Giannadaki E; Hooghe F; Roels K; Van Gansbeke W; Garribba F; Lyris E; Deventer K; Mazzarino M; Donati F; Georgakopoulos DG; Van Eenoo P; Georgakopoulos CG; de la Torre X; Botrè F Drug Test Anal; 2017 May; 9(5):699-712. PubMed ID: 27497113 [TBL] [Abstract][Full Text] [Related]
2. Stabilization of human urine doping control samples: a current opinion. Tsivou M; Georgakopoulos DG; Dimopoulou HA; Koupparis MA; Atta-Politou J; Georgakopoulos CG Anal Bioanal Chem; 2011 Aug; 401(2):553-61. PubMed ID: 21499681 [TBL] [Abstract][Full Text] [Related]
3. Stabilization of human urine doping control samples: IV. Human chorionic gonadotropin. Tsivou M; Dimopoulou HA; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG Anal Bioanal Chem; 2010 Oct; 398(3):1313-8. PubMed ID: 20658279 [TBL] [Abstract][Full Text] [Related]
4. Stabilization of human urine doping control samples: III. Recombinant human erythropoietin. Tsivou M; Dimopoulou HA; Leontiou IP; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG Clin Chim Acta; 2010 Mar; 411(5-6):448-52. PubMed ID: 19958754 [TBL] [Abstract][Full Text] [Related]
5. Stabilization of human urine doping control samples: II. microbial degradation of steroids. Tsivou M; Livadara D; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG Anal Biochem; 2009 May; 388(1):146-54. PubMed ID: 19232313 [TBL] [Abstract][Full Text] [Related]
6. Fluorescence flow cytometer to determine urine particle reference intervals in doping control samples. Robinson N; Sottas PE; Saugy M Forensic Sci Int; 2011 Dec; 213(1-3):95-100. PubMed ID: 21889276 [TBL] [Abstract][Full Text] [Related]
7. Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H; Schänzer W Drug Test Anal; 2017 Jan; 9(1):6-29. PubMed ID: 27885819 [TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls. Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079 [TBL] [Abstract][Full Text] [Related]
9. Anti-doping testing at the 2008 European football championship. Vouillamoz M; Thom C; Grisdale R; Saugy M; Giraud S; Robinson N; Gmeiner G; Geisendorfer T Drug Test Anal; 2009 Nov; 1(11-12):485-93. PubMed ID: 20355163 [TBL] [Abstract][Full Text] [Related]
10. Implementation of a marker substance for monitoring in situ 17-keto modifications in endogenous steroids caused by microbiological contamination. Pfeffer S; Gmeiner G; Gärtner P Drug Test Anal; 2022 Nov; 14(11-12):1871-1876. PubMed ID: 35128824 [TBL] [Abstract][Full Text] [Related]
11. Pilot study on the effects of intravesical oxybutynin hydrochloride instillations on the validity of doping control urine samples. Walpurgis K; Scheiff AB; Welz M; Müller-Reul J; Webborn N; Görgens C; Guddat S; Fußhöller G; Dib J; Thevis M Drug Test Anal; 2019 Nov; 11(11-12):1755-1760. PubMed ID: 31670462 [TBL] [Abstract][Full Text] [Related]
12. Speeding up the process urine sample pre-treatment: some perspectives on the use of microwave assisted extraction in the anti-doping field. Mazzarino M; Riggi S; de la Torre X; Botrè F Talanta; 2010 Jun; 81(4-5):1264-72. PubMed ID: 20441894 [TBL] [Abstract][Full Text] [Related]
13. lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls. Eichner D; Van Wagoner RM; Brenner M; Chou J; Leigh S; Wright LR; Flippin LA; Martinelli M; Krug O; Schänzer W; Thevis M Drug Test Anal; 2017 Nov; 9(11-12):1768-1778. PubMed ID: 28378453 [TBL] [Abstract][Full Text] [Related]
14. "Application of the ultra micro analytical system (SUMA) technology for the detection of urinary hCG in antidoping control". Martinez Brito D; Bueno Fis E; Fiallo Fernandez T; Torres Castellanos M; Correa Vidal MT; Montes De Oca Porto R J Immunoassay Immunochem; 2018; 39(6):672-686. PubMed ID: 30346873 [TBL] [Abstract][Full Text] [Related]
15. Sports drug testing: Analytical aspects of selected cases of suspected, purported, and proven urine manipulation. Thevis M; Geyer H; Sigmund G; Schänzer W J Pharm Biomed Anal; 2012 Jan; 57():26-32. PubMed ID: 21955645 [TBL] [Abstract][Full Text] [Related]
16. Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control. Kuuranne T; Ahola L; Pussinen C; Leinonen A Drug Test Anal; 2013 Aug; 5(8):614-8. PubMed ID: 23303576 [TBL] [Abstract][Full Text] [Related]
17. [Medication, athletes and doping regulations]. Hartgens F Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164 [TBL] [Abstract][Full Text] [Related]
18. Solid-phase extraction of small biologically active peptides on cartridges and microelution 96-well plates from human urine. Semenistaya E; Zvereva I; Krotov G; Rodchenkov G Drug Test Anal; 2016 Sep; 8(9):940-9. PubMed ID: 26472487 [TBL] [Abstract][Full Text] [Related]
19. Urine reference intervals for human chorionic gonadotropin (hCG) isoforms by immunoextraction-tandem mass spectrometry to detect hCG use. Butch AW; Ahrens BD; Avliyakulov NK Drug Test Anal; 2018 Jun; 10(6):956-960. PubMed ID: 29098788 [TBL] [Abstract][Full Text] [Related]
20. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls. Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]